BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 11421935)

  • 21. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
    Spahr JE; Krawiec ME
    Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-leukotrienes for asthma.
    Calhoun WJ
    Curr Opin Pharmacol; 2001 Jun; 1(3):230-4. PubMed ID: 11712744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Montelukast in childhood asthma: what is the evidence for its use?
    Amlani S; McIvor RA
    Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antileukotriene treatment in children with asthma--new patents.
    Stelmach I; Grzelewski T
    Recent Pat Inflamm Allergy Drug Discov; 2008 Nov; 2(3):202-11. PubMed ID: 19076010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.
    Warner JO
    Allergy; 2001; 56 Suppl 66():22-9. PubMed ID: 11421938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukotriene modifiers as novel therapeutics in asthma.
    Leff JA
    Clin Exp Allergy; 1998 Nov; 28 Suppl 5():147-53; discussion 171-3. PubMed ID: 9988461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asthma treatment: antileukotriene drugs.
    O'Byrne PM
    Can Respir J; 1998; 5 Suppl A():64A-70A. PubMed ID: 9753521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation.
    Sampson AP; Pizzichini E; Bisgaard H
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S49-59; discussion S59-61. PubMed ID: 12532086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukotrienes in asthma. The potential therapeutic role of antileukotriene agents.
    Smith LJ
    Arch Intern Med; 1996 Oct; 156(19):2181-9. PubMed ID: 8885816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of aspirin-intolerant asthma with antileukotrienes.
    Dahlén B
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S137-41. PubMed ID: 10673243
    [No Abstract]   [Full Text] [Related]  

  • 33. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Diamant Z; Sterk PJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antileukotrienes in clinical development for asthma.
    Centanni S; Santus P
    Expert Opin Investig Drugs; 2002 Jan; 11(1):49-58. PubMed ID: 11772320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation.
    Peters-Golden M; Sampson AP
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S37-42; discussion S43-8. PubMed ID: 12532085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotriene inhibitors and antagonists in asthma.
    Spector SL
    Ann Allergy Asthma Immunol; 1995 Dec; 75(6 Pt 1):463-70, 473; quiz 473-4. PubMed ID: 8603274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.
    Matsuse H; Kohno S
    Expert Opin Pharmacother; 2014 Feb; 15(3):353-63. PubMed ID: 24350802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of asthma with zafirlukast. Clinical experience and tolerability profile.
    Spector SL
    Drugs; 1996; 52 Suppl 6():36-46. PubMed ID: 8941502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukotrienes and the mechanism by which the LTRAs block their asthma-related effects.
    Spector SL
    Postgrad Med; 2000 Sep; 108(4 Suppl):6-11. PubMed ID: 19667529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.